RecruitingPhase 3NCT06307665
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor: AstraZeneca
Austin, TX · Baytown, TX · Beaumont, TX · +117 more sites
Clinical trials in Kerrville, TX
8 recruiting studies have a site in or near Kerrville, TX, Texas.
Top conditions here
- Asthma (3)
- COPD (2)
- Obesity (1)
- Type 1 Diabetes (1)
- Type 2 Diabetes (1)
- Migraine (1)
- Alzheimer's Disease (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 8 of 8 studies
RecruitingPhase 3NCT07276724
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
Sponsor: Generate Biomedicines
Amarillo, TX · Baytown, TX · Dallas, TX · +33 more sites
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Abilene, TX · Amarillo, TX · Austin, TX · +232 more sites
RecruitingPhase 3NCT05757102
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Sponsor: GlaxoSmithKline
Dallas, TX · Kerrville, TX · Plano, TX · +25 more sites
RecruitingPhase 3NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Amarillo, TX · Austin, TX · +96 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Austin, TX · +122 more sites
RecruitingPhase 3NCT06883305
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Sponsor: AstraZeneca
Dallas, TX · Forney, TX · Fort Worth, TX · +70 more sites
RecruitingPhase 3NCT05641688
[18F]PI-2620 Phase 3 Histopathological Study
Sponsor: Lantheus Biosciences Ltd.
Dallas, TX · Kerrville, TX · Round Rock, TX · +22 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.